BioXcel Therapeutics, Inc. (BTAI)
1.81
-0.03
(-1.63%)
USD |
NASDAQ |
Jan 22, 16:00
1.82
+0.01
(+0.55%)
After-Hours: 20:00
BioXcel Therapeutics Market Cap: 39.58M for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xilio Therapeutics, Inc. | 32.41M |
| NovaBay Pharmaceuticals, Inc. | 691.43M |
| Palatin Technologies, Inc. | 15.52M |
| Theriva Biologics, Inc. | 6.981M |
| Oragenics, Inc. | 0.7632M |
Market Cap Related Metrics
| PS Ratio | 18.00 |
| PEG Ratio | -0.0005 |
| Price | 1.81 |
| Earnings Yield | -535.8% |
| PEGY Ratio | -0.0005 |